Yayınlar & Eserler

Yayın Ağı
Makaleler 67
Tümü (67)
SCI-E, SSCI, AHCI (48)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (1)
Scopus (59)
TRDizin (7)
Diğer Yayınlar (3)

1. Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)

Akkus E., Kayaalp M., Ergözoğlu M. A., Koç Kuş I., Bayram D., Kılıçtaş B., et al.
JCO global oncology , cilt.12, sa.3, 2026 (ESCI, Scopus) identifier identifier

2. Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

Şahin G., Tüzün E. K., Güzel H. G., Guliyev M., Dişli A. K., YAZICI M., et al.
International Journal of Cancer , cilt.158, sa.4, ss.1067-1079, 2026 (SCI-Expanded, Scopus) identifier identifier

3. Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial

Paterson D. L., Sulaiman H., Liu P., Chatfield M. D., YILMAZ M., Salmuna Z. N., et al.
The Lancet Infectious Diseases , cilt.26, sa.2, ss.148-159, 2026 (SCI-Expanded, Scopus) identifier identifier

4. Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study

Aslan A. T., TANRIVERDİ E. S., Kaya S. Y., Dalgan G., SALTOĞLU N., YILMAZ E., et al.
International Journal of Antimicrobial Agents , cilt.67, sa.1, 2026 (SCI-Expanded, Scopus) identifier identifier

5. Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

Sahin T. K., Kemik F., MUĞLU H., Acikgöz Yildiz B., Biter S., Tunbekici S., et al.
Therapeutic Advances in Medical Oncology , cilt.18, 2026 (SCI-Expanded, Scopus) identifier identifier

6. Characterization of drug-related problems in gram-negative bloodstream infections with clinical pharmacist input - a prospective study

AYDIN S., ÇAKMAK R., ŞAHİN M., güner yeniaydın e., KÖK K., YILMAZ M.
ACTA Pharmaceutica Sciencia , cilt.63, sa.3, 2025 (Hakemli Dergi) Creative Commons License

7. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Loiodice A., Bailly S., Ruckly S., Buetti N., Barbier F., Staiquly Q., et al.
Clinical Microbiology and Infection , cilt.30, sa.12, ss.1559-1568, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

8. Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study

Şahin M., Yılmaz M., Mert A., Emecen A. N., Rahman S. Al Maslamani M. A., Mahmoud A. Hashim S., et al.
HELIYON , cilt.10, sa.14, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

9. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study

Şahin M., Yılmaz M., Mert A., Naghili B., Ravanbakhsh F., Varshochi M., et al.
MEDICAL MYCOLOGY , cilt.62, sa.7, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

10. Stenotrophomonas maltophilia outbreak originating from a pull-out faucet in a pediatric intensive care unit in Turkey: Insights from clinical records and molecular typing

Yashar M., Basarir K. E., Tanriverdi E. S., Celep S., Sirekbasan L., RAKICI E., et al.
American Journal of Infection Control , cilt.52, sa.5, ss.605-610, 2024 (SCI-Expanded, Scopus) identifier identifier

11. Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial

Omrani A. S., Abujarir S. H., Ben Abid F., Shaar S. H., YILMAZ M., Shaukat A., et al.
Clinical Microbiology and Infection , cilt.30, sa.4, ss.492-498, 2024 (SCI-Expanded, Scopus) identifier identifier

12. Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemia

AYDIN S., MERT A., YILMAZ M., Al Maslamani M., Rahimi B. A., Ayoade F., et al.
Mycoses , cilt.67, sa.1, 2024 (SCI-Expanded, Scopus) identifier identifier

13. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study

Erdem H., Kocoglu E., Ankarali H., El-Sokkary R., Hakamifard A., KARAALİ R., et al.
International journal of antimicrobial agents , cilt.62, sa.3, ss.106919, 2023 (SCI-Expanded, Scopus) identifier identifier

14. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study

Aslan A. T., Tabah A., Köylü B., Kalem A. K., AKSOY F., Erol Ç., et al.
The Journal of antimicrobial chemotherapy , cilt.78, sa.7, ss.1757-1768, 2023 (SCI-Expanded, Scopus) identifier identifier

15. Development of a new multiplex real-time PCR assay for rapid screening of hospital-acquired infection agents

Tosun A., Kolukirik M., YILMAZ M., Ötgün S. N., AYGÜN G., Kolukirik C. Z. K., et al.
JOURNAL OF MICROBIOLOGICAL METHODS , cilt.206, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

16. Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study)

Pascale R., Toschi A., Aslan A. T., Massaro G., Maccaro A., Fabbricatore D., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , cilt.61, sa.3, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

17. Infectious side effects of baricitinib: A big data analysis based on VigiBase

MAHROUM N., Ozkan M. F., Abali T., YILMAZ M., Bragazzi N. L.
Autoimmunity Reviews , cilt.22, sa.1, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

18. Acute Disseminated Encephalomyelitis Following Completion of Pneumococcal Meningitis Treatment: A Case Report and Review of the Literature

Ozel A. S., Altunal L. N., Sakci Z., Yilmaz E. A., Yilmaz M., Kadanali A.
MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.12, 2023 (Hakemli Dergi) identifier identifier

19. Diagnosis of Covid-19 Via Patient Breath Data Using Artificial Intelligence

DOĞUÇ Ö., SİLAHTAROĞLU G., Canbolat Z. N., Hambarde K., Yiğitbaşı A. A., Gökay H., et al.
Emerging Science Journal , cilt.7, sa.Special issue, ss.105-113, 2023 (Scopus) Creative Commons License identifier

20. A Multi-center Retrospective Analysis of Healthcare Workers after COVID-19: Epidemiological and Clinical Features

Derin O., AKSOY N., Çaydaşı Ö., YILMAZ M., MERT A.
Clinical and Experimental Health Sciences , cilt.12, sa.3, ss.697-701, 2022 (TRDizin) Creative Commons License identifier identifier

21. The Effect of Antimicrobial Policy Implementation on Carbapenem Resistance: A University Hospital Experience

Derin O., Seker F., AKSOY N., YİĞİT P., YILMAZ M., MERT A.
Clinical and Experimental Health Sciences , cilt.12, sa.3, ss.678-682, 2022 (TRDizin) Creative Commons License identifier identifier

22. A Case of Endocarditis due to Coxiella burnetii Coxiella burnetii’ye Bağlı Bir Endokardit Olgusu

AYDIN S., DERİN O., YILMAZ M.
Mediterranean Journal of Infection, Microbes and Antimicrobials , 2022 (Scopus)

23. Epidemiology of Nosocomial Candidemia, Mortality, and Antifungal Resistance: 7-Year Experience in Turkey

AYDIN S., Derin O., ŞAHİN M., Dinleyici R., YILMAZ M., CEYLAN B., et al.
Japanese Journal of Infectious Diseases , cilt.75, sa.6, ss.597-603, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

24. A Case of Endocarditis due to Coxiella burnetii Coxiella burnetiiye Bagli Bir Endokardit Olgusu

AYDIN S., Dern O., YILMAZ M.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.11, 2022 (Scopus) Creative Commons License identifier identifier

25. Clinical and microbiological characteristics of Aeromonas bacteremia in Turkey.

Kaya A., Kaya S. Y., Zerdali E., Koç A., Çaǧlar B., Ertürk Ü. S., et al.
Acta microbiologica et immunologica Hungarica , cilt.68, sa.4, ss.267-272, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

26. Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.

Henderson A., Paterson D. L., Chatfield M. D., Tambyah P. A., Lye D. C., De P. P., et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , cilt.73, sa.11, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

27. A brief report: Cerebrospinal fluid rhinorrhea after repetitive nasal swab testing for coronavirus disease 2019(COVID-19)

YILMAZ M., Bahadır Z., Madendere B., Yüksel R. T., Gökay H., Yiğitbaşı A. A.
Otolaryngology Case Reports , cilt.20, 2021 (Scopus) identifier identifier

28. Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Stewart A. G., Paterson D. L., Young B., Lye D. C., Davis J. S., Schneider K., et al.
Open Forum Infectious Diseases , cilt.8, sa.8, 2021 (SCI-Expanded, Scopus) identifier identifier

29. A Case of Granulomatous Mastitis due to Corynebacterium amycolatum

Bahadir Z., Kalkan N. B., YILMAZ M.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (Scopus) Creative Commons License identifier identifier

30. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa

MATARACI KARA E., YILMAZ M., İSTANBULLU TOSUN A., ÖZBEK ÇELİK B.
Infectious Diseases , cilt.52, sa.9, ss.616-624, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

31. In Vitro Synergistic Effect and Mutant Prevention Concentrations of Cefepime Alone or in Combination with Sulbactam Against OXA-48-positive Klebsiella pneumoniae Isolates

Mataracı-Kara E., YILMAZ M., Özbek-Çelik B.
Current Microbiology , cilt.77, sa.9, ss.2137-2142, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

32. Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales

MATARACI KARA E., YILMAZ M., İSTANBULLU TOSUN A., ÖZBEK ÇELİK B.
Journal of Chemotherapy , cilt.32, sa.4, ss.171-178, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

33. Can procalcitonin levels differentiate gram-negative bacteremia from gram-positive bacteremia?

OLMUŞÇELİK O., YILMAZ M., SEVİNDİK Ö. G., İSTANBULLU TOSUN A., CEYLAN E. C., VARDAR B.
Fırat University Journal of Health Sciences , cilt.33, sa.2, ss.83-87, 2019 (TRDizin) identifier

34. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates

MATARACI KARA E., YILMAZ M., ÖZBEK ÇELİK B.
Journal of Global Antimicrobial Resistance , cilt.17, ss.137-141, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

35. Antibiotic overconsumption and resistance in Turkey.

Isler B., Keske Ş., Aksoy M., Azap Ö. K., Yilmaz M., Yavuz S. Ş., et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases , cilt.25, sa.6, ss.651-653, 2019 (SCI-Expanded, Scopus) identifier

36. Hydatid disease of the liver with portal vein invasion mimicking portal vein thrombosis

Ertan G., Ulus S., Kilicarslan R., YILMAZ M., Paksoy Y., EROL C.
Arab Journal of Gastroenterology , cilt.20, sa.1, ss.50-52, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

37. Primary gastrointestinal aspergillosis: A case report and literature review

CEYLAN B., YILMAZ M., BEKÖZ H. S., Ramadan S., Akan G. E., MERT A.
Infezioni in Medicina , cilt.27, sa.1, ss.85-92, 2019 (Scopus) identifier identifier

38. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance

Harris P. N. A., Tambyah P. A., Lye D. C., Mo Y., Lee T. H., YILMAZ M., et al.
JAMA - Journal of the American Medical Association , cilt.320, sa.10, ss.984-994, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

39. Human Herpesvirus 6 encephalitis in an immunocompetent pregnant patient and review of the literature

YILMAZ M., Yasar C., AYDIN S., Derin O., POLAT B., Ertan G., et al.
Clinical Neurology and Neurosurgery , cilt.171, ss.106-108, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

40. Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.

Yilmaz M., Yasar C., Aydin S., Derin O., Ceylan B., Mert A.
Drug safety - case reports , cilt.5, sa.1, ss.9, 2018 (Hakemli Dergi) Creative Commons License identifier

41. Perioperatif Antimikrobiyal Profilaksi Uygulamalarında Rehberlere Uyum: Çok Merkezli Bir Çalışma

KOÇAK F., BALKAN İ. İ., ÇELİK A. D., DURDU B., DEMİREL A., GENÇER S., et al.
ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ , cilt.22, sa.1, ss.8-15, 2017 (TRDizin) identifier

42. Variables determining mortality in patients with Acinetobacter baumannii meningitis/ventriculitis treated with intrathecal colistin

CEYLAN B., Arslan F., Sipahi O. R., Sunbul M., Ormen B., Hakyemez İ. N., et al.
Clinical Neurology and Neurosurgery , cilt.153, ss.43-49, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

43. Miliary tuberculosis

MERT A., Arslan F., Kuyucu T., Koç E. N., YILMAZ M., Turan D., et al.
Medicine (United States) , cilt.96, sa.5, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

44. Development of a fast and low-cost qPCR assay for diagnosis of acute gas pharyngitis

Kolukirik M., YILMAZ M., İnce O., Ketre C., Tosun A. I., Ince B. K.
Annals of Clinical Microbiology and Antimicrobials , cilt.15, sa.1, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

45. İDRAR YOLU İNFEKSİYONLARINDAN İZOLE EDİLEN ESCHERICHIA COLI VE KLEBSIELLA PNEUMONIAE SUŞLARININ ANTİMİKROBİYAL DİRENÇ ORANLARI

İSTANBULLU TOSUN A., Demirci M., YILMAZ M., ŞEN H., SİREKBASAN L., GÖZÜN ŞAYLAN E., et al.
ANKEM Dergisi , cilt.30, sa.1, ss.1-6, 2016 (TRDizin) identifier

46. Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study

YILMAZ M., ELALDI N., BALKAN İ. İ., Arslan F., Batlrel A. A., Baklcl M. Z., et al.
Annals of Clinical Microbiology and Antimicrobials , cilt.15, sa.1, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

47. Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir

CEYLAN B., Arslan F., Batirel A., Fincanci M., Yardimci C., Fersan E., et al.
Turkish Journal of Gastroenterology , cilt.27, sa.1, ss.42-46, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

48. Recurrent pancreatitis induced by metronidazole re-exposure and a review of the current literature

YILMAZ M., Kinikoglu O., Ceylan B., Arslan F., Mert A.
Acta Gastro-Enterologica Belgica , cilt.79, sa.3, ss.389-390, 2016 (Scopus) identifier identifier identifier

49. Metastatic prostate cancer as an infrequent cause of fever of unknown origin, and review of the literature

YILMAZ M., Arslan F., ÖRMECİ T., MERT A.
European Journal of Oncology , cilt.21, sa.4, ss.243-245, 2016 (Scopus) identifier

50. In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant Enterobacteriaceae strains

Ozbek B., Mataraci-Kara E., Er S., Ozdamar M., YILMAZ M.
Journal of Global Antimicrobial Resistance , cilt.3, sa.4, ss.278-282, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

51. The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study.

Arslan F., Meynet E., Sunbul M., Sipahi O., KURTARAN B., KAYA S., et al.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology , cilt.34, sa.6, ss.1213-21, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

52. Bed capacities and disinfection practices in hospitals in Istanbul are correlated

Teker B., Ogutlu A., YILMAZ M., Gencer S., Karabay O.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , cilt.14, sa.1, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

53. Visual vignette.

Arslan F., Karagoz E., Yılmaz M., Mert A.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.21, sa.3, ss.299, 2015 (SCI-Expanded, Scopus) identifier

54. Cytomegalovirus-associated transverse myelitis: A review of nine well-documented cases

Arslan F., YILMAZ M., Paksoy Y., Karagöz E., MERT A.
Infectious Diseases , cilt.47, sa.1, ss.7-12, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

55. Hepatic granulomas: etiologic distribution.

Mert A., Yılmaz M., Ceylan B., Aslan F.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.25, sa.5, ss.529-30, 2014 (SCI-Expanded, Scopus, TRDizin) identifier

56. Splenic abscess due to brucellosis: A case report and a review of the literature

YILMAZ M., Arslan F., Başkan Ö., MERT A.
International Journal of Infectious Diseases , cilt.20, sa.1, ss.68-70, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

57. Significant contribution of Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in a case of acute lymphoblastic leukemia presenting with fever of unknown origin

Arslan F., YILMAZ M., ÇAKIR T., MERT A.
Internal Medicine , cilt.53, sa.7, ss.789-791, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

58. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin

Jayol A., Poirel L., Brink A., Villegas M., YILMAZ M., Nordmann P.
Antimicrobial Agents and Chemotherapy , cilt.58, sa.8, ss.4762-4766, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

59. Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit

ÖZBEK ÇELİK B., Mataraci-Kara E., YILMAZ M.
BioMed Research International , cilt.2014, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

60. Spread of NDM-1-producing enterobacteriaceae in a neonatal intensive care unit in istanbul, turkey

Poirel L., YILMAZ M., Istanbullu A., Arslan F., MERT A., Bernabeu S., et al.
Antimicrobial Agents and Chemotherapy , cilt.58, sa.5, ss.2929-2933, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

61. Community Acquired Chronic Arthritis due to Pseudomonas aeruginosa in a Previously Healthy Pregnant Woman.

Yilmaz M., Arslan F., Mert A.
Case reports in infectious diseases , cilt.2014, ss.272306, 2014 (Hakemli Dergi) Creative Commons License identifier

62. A fatal case of urosepsis due to corynebacterium riegelii

AYGÜN G., Midilli K., Cilingir H., YILMAZ M., Kutukcu A., Eker E.
Brazilian Journal of Microbiology , cilt.44, sa.2, ss.475-476, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

63. Community-acquired left-sided Pseudomonas aeruginosa endocarditis in a patient without intravenous drug use

YILMAZ M., Sunar H., MERT A.
Infection , cilt.41, sa.1, ss.243-245, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

64. Prospective observational study on antibiotic-associated bloody diarrhea: report of 21 cases with a long-term follow-up from Turkey

YILMAZ M., Bilir Y. A., AYGÜN G., ERZİN Y. Z., Ozturk R., ÇELİK A. F.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.24, sa.6, ss.688-694, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

65. A patient with HIV infection presenting with diffuse membranous glomerulonephritis in a country with a low HIV prevalence--remarkable remission with therapy.

Aydin S., METE B., YILMAZ M., YENİDÜNYA YALIN G., Zaras R., Tunckale A., et al.
Journal of infection and public health , cilt.5, sa.2, ss.207-10, 2012 (Scopus) Sürdürülebilir Kalkınma identifier identifier

66. Anorectal syphilis mimicking Crohn's disease.

YILMAZ M., Memisoglu R., Aydin S., Tabak O., METE B., Memisoglu N., et al.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , cilt.17, sa.5, ss.713-5, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

67. Aspergillus fumigatus infection as a delayed manifestation of prosthetic knee arthroplasty and a review of the literature

YILMAZ M., METE B., Özaras R., KAYNAK G., Tabak F., Tenekecioǧlu Y., et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , cilt.43, sa.8, ss.573-578, 2011 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. Impact of multiplexed upper respiratory panels on antimicrobial stewardship

Yılmaz M., Aydın S., Şahin M., Sirekbakan L., İstanbullu Tosun A.
34th ECCMID 2024, Barcelona, İspanya, 27 Nisan 2024, (Özet Bildiri)

2. Probleme Dayalı Öğrenmede Yakın Akran Yönlendiricilerinin Öğrenme Sürecine Etkisi

Akan H., Yiğit P., Çopur Çiçek A., Yılmaz M.
13. Ulusal Tıp Eğitimi Kongresi, Ankara, Türkiye, 16 - 18 Kasım 2023, ss.50-51, (Özet Bildiri) Creative Commons License

3. MEZUNİYET ÖNCESİ TIP EĞİTİMİ ORTAMININ DEĞERLENDİRİLMESİ: BİR VAKIF ÜNİVERSİTESİ İKİ TIP FAKÜLTESİ ÖRNEĞİ

Dirimen Arıkan A. G., Çopur Çiçek A., Yiğit P., Yılmaz M., Bayraktaroğlu Z., Akan H.
XIII. Ulusal Tıp Eğitimi Kongresi, Ankara, Türkiye, 16 - 18 Kasım 2023, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Sağlık Turizmi Kapsamında Hizmet Alan Yabancı Uyruklu Erişkin Hastaların İdrar Kültürlerinde Üreyen Klebsiella pneumoniae İzolatlarının Antibiyotik Direnç Profilleri

Öz N. Z., Uğur F. N., AYDOĞAN O., İSTANBULLU TOSUN A., YILMAZ M., ÇOPUR ÇİÇEK A.
7. Ulusal Klinik Mikrobiyoloji Kongresi, Muğla, Türkiye, 1 - 05 Kasım 2023, (Özet Bildiri)

5. Diagnosis of Covid-19 Via Patient Breath Data Using Artificial Intelligence

SİLAHTAROĞLU G., DOĞUÇ Ö., Hambarde K., CANBOLAT Z. N., Yiğitbaşı A. A., Gökay H., et al.
AKIP 2022 2nd INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE &KNOWLEDGE PROCESSING, Hindistan, 22 - 23 Temmuz 2022, ss.9-10, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Sepsis Mikrobiyal Etkenlerinin Kan Kültüründen Bağımsız Hızlı Tespiti İçin Eş Zamanlı PZR Temelli Bir Yöntem Geliştirilmesi

İSTANBULLU TOSUN A., YILMAZ M., KOLUKIRIK M., ZEYBEK Ş. Ü., ERGEN H. A., AYGÜN G.
5. Ulusal Klinik Mikrobiyoloji Kongresi, İzmir, Türkiye, 28 Ekim - 01 Kasım 2019, ss.229-231, (Özet Bildiri)

7. Development of a new multiplex real-time PCR assay for rapid screening of hospital-acquired infection agents

İSTANBULLU TOSUN A., KOLUKIRIK M., YILMAZ M., NAR ÖTGÜN S., AYGÜN G., KETRE KOLUKIRIK C. Z., et al.
7th International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.102-104, (Özet Bildiri)

8. Evaluation of four novel multiplex real-time PCR panels for syndromic testing

KOLUKIRIK M., KILIÇ S., BAYRAKDAR F., NAR ÖTGÜN S., GİRGİN ÖZGÜMÜŞ G., KETRE KOLUKIRIK C. Z., et al.
7th Iternational Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.100-101, (Özet Bildiri)

9. Kan Kültüründe Üreyen Gram Negatif Bakterilerin Direkt Antimikrobik Duyarlılık Test Snuçlarının Standart Antimikrobik Duyarlılık Sonuçları İle Karşılaştırılması

İSTANBULLU TOSUN A., YILMAZ M., SEVER C.
38. Uluslararası Türk Mikrobiyoloji Kongresi, Antalya, Türkiye, 4 - 08 Kasım 2018, ss.196, (Özet Bildiri)

10. Bir üniversite hastanesinde sezaryan öncesi uygun profilaktik antibiyotik kullanımında klinik eczacının etkisi

dinleyici r., MACİT Ç., YILMAZ M.
3. Ulusal klinik eczacılık farmasötik bakım kongresi, Antalya, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri)

11. Bir Vaka Dolayısı ile; Nadir Bir Mikroorganizmada NDM-1

İSTANBULLU TOSUN A., ÖZDAMAR M., YILMAZ M.
XXXVI. Türk Mikrobiyoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2014, ss.392, (Özet Bildiri)

12. İstanbul’da karbapenemaz(NDM-1 ve KPC) tehdidi: Çok geç olmadan durdurulmalı

YILMAZ M., İSTANBULLU TOSUN A., ARSLAN F., POİREL L., NORDMAN P., MERT A.
5. Türkiye EKMUD Kongresi, Antalya, Türkiye, 21 - 25 Mayıs 2014, ss.184, (Özet Bildiri)

13. İstanbuldaki özel hastanelerde dezenfeksiyon antisepsi ve sterilizasyon pratigi

TEKER B., ÖĞÜTLÜ A., YILMAZ M., GENCER S., KARABAY O.
EKMUD 2013 BİLİMSEL PLATFORMU, Antalya, Türkiye, 20 - 24 Mart 2013, ss.179, (Özet Bildiri)

14. Tedaviye cevapsız kötü kokulu burun akıntılı bir hastada saptanan ozena

TEKER B., EVCİMİK M. F., SEVER N., YILMAZ M.
EKMUD 2013 BİLİMSEL PLATFORMU, Antalya, Türkiye, 20 - 24 Mart 2013, ss.234-235, (Özet Bildiri)

15. Boğaz kültüründen elde edilen beta hemolitik streptokokların antibiyotik duyarlılıkları

YILMAZ M., ATEŞ S., SEVER N., TEKER B., ARSLAN F., MERT A.
EKMUD 2013 BİLİMSEL PLATFORMU, Antalya, Türkiye, 20 - 24 Mart 2013, ss.203, (Özet Bildiri)
Kitaplar 1

1. INFECTIONS AND BEHÇET DISEASE

Şahin M., Correıa J., Campar A., Ferrao C., Serpa Pınto L., Vasconcelos C., et al.
INFECTION AND AUTOIMMUNITY, WATAD ABDULLA,MAHROUM NAIM,SHOENFELD YEHUDA, Editör, Academic Press , New York, ss.807-822, 2024 Creative Commons License
Metrikler

Yayın

83

Yayın (WoS)

55

Yayın (Scopus)

59

Atıf (Scopus)

1785

H-İndeks (Scopus)

17

Atıf (TrDizin)

12

H-İndeks (TrDizin)

2

Proje

8

Tez Danışmanlığı

2

Açık Erişim

22
BM Sürdürülebilir Kalkınma Amaçları